summary
Introduced
10/22/2015
10/22/2015
In Committee
03/02/2016
03/02/2016
Crossed Over
03/02/2016
03/02/2016
Passed
03/11/2016
03/11/2016
Dead
Signed/Enacted/Adopted
04/14/2016
04/14/2016
Introduced Session
2016 Regular Session
Bill Summary
Expanding the categories of persons who may prescribe brand name drugs under the prescription drug program when medically necessary; requiring advanced registered nurse practitioners and physician assistants who prescribe controlled substances for the treatment of certain pain to make a certain designation, comply with registration requirements, and follow specified standards of practice; designates "The Barbara Lumpkin Prescribing Act", etc.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (9)
Daphne Campbell (D)*,
Cary Pigman (R)*,
Neil Combee (R),
Erik Fresen (R),
Christopher Latvala (R),
Holly Raschein (R),
Hazelle Rogers (D),
Darryl Rouson (D),
Charles Van Zant (R),
Last Action
Chapter No. 2016-224, companion bill(s) passed, see CS/CS/CS/HB 221 (Ch. 2016-222), CS/HB 977 (Ch. 2016-231), HB 1241 (Ch. 2016-145) (on 04/14/2016)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...